Yohko Fujimoto

1.2k citations
91 papers · 1.1k indexed · h-index 17

Yohko Fujimoto

90 papers receiving 1.0k citations

Peers

Yohko Fujimoto
Comparison fields: 5 of 98
  • Biochemistry 248
  • Health, Toxicology and Mutagenesis 211
  • Pharmacology 194
  • Nephrology 80
  • Clinical Biochemistry 76
Replace Lining Miao with:
Lining Miao China
Xiao Miao China
James W. Kaspar United States
Tülay Akçay Türkiye
Reiko Akagi Japan
Giuliano Ciofani Italy
Mahvash Jafari Iran
C. Cojocel Germany
Ahad Noor Khan Yusufi India
Jing Shao China
Yohko Fujimoto relative to Lining Miao China Lining Miao's profile →
Citations per field
00.5×1.5×2.3×
Lining Miao · 1×
Citations per year

Countries citing papers authored by Yohko Fujimoto

Since Specialization
Citations

This map shows the geographic impact of Yohko Fujimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yohko Fujimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yohko Fujimoto more than expected).

Fields of papers citing papers by Yohko Fujimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yohko Fujimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yohko Fujimoto. The network helps show where Yohko Fujimoto may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yohko Fujimoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yohko Fujimoto Line = papers co-authored together Yohko Fujimoto links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1
The peptide glycyl-ʟ-histidyl-ʟ-lysine is an endogenous antioxidant in living organisms, possibly by diminishing hydroxyl and peroxyl radicals.
201812
2 20162
3 201412
4 201016
5 200913
6 200778
7 20056
8 20048
9 20037
10 200242
11 20009
12 199915
13 199818
14 199746
15 19932
16 199213
17 199214
18 19915
19 199026
20 198412

About Yohko Fujimoto

Yohko Fujimoto is a scholar working on Biochemistry, Nephrology and Clinical Biochemistry, having authored 91 papers that have together received 1.1k indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (27 papers), Inflammatory mediators and NSAID effects (24 papers), Metabolism and Genetic Disorders (11 papers), Peroxisome Proliferator-Activated Receptors (10 papers), Nitric Oxide and Endothelin Effects (9 papers), Gout, Hyperuricemia, Uric Acid (9 papers), Fatty Acid Research and Health (8 papers) and Vitamin K Research Studies (6 papers). The work is most often cited by research in Biochemistry (248 citations), Health, Toxicology and Mutagenesis (211 citations) and Pharmacology (194 citations). Yohko Fujimoto has collaborated with scholars based in Japan. Frequent co-authors include Satoru Sakuma, Tadashi Fujita, Hiroko Nishida, Tadashi Fujita, Yoshinori Kamisaki, Atsushi Nakajima, Hidetoshi Tanioka, Koichiro Wada, Koichiro Wada and Chiho Kudo. Their work appears in journals such as SHILAP Revista de lepidopterología, Biochemical Journal and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026